NOTE 11: INCOME TAXES

 

Income (loss) before income tax:

Year Ended December 31,

(in thousands)

2025

 

2024

 

2023

Domestic

$

(4,780)

 

$

63,403

 

$

19,942

Foreign

 

13,641

 

 

8,133

 

 

7,903

Income before income taxes

$

8,861

 

$

71,536

 

$

27,845

 

Provision for (benefit from) income taxes:

Year Ended December 31,

(in thousands)

2025

 

2024

 

2023

Current:

 

 

 

 

 

 

 

 

Federal

$

1,221

 

$

27,600

 

$

16,618

State

 

358

 

 

6,317

 

 

3,766

Foreign

 

2,884

 

 

2,402

 

 

1,794

Deferred:

 

 

 

 

 

 

 

 

Federal

 

3,514

 

 

(16,743)

 

 

(77,450)

State

 

628

 

 

(790)

 

 

(6,181)

Foreign

 

(960)

 

 

2,032

 

 

960

Total provision for (benefit from) income taxes

$

7,645

 

$

20,818

 

$

(60,493)

 

As described in Note 2, "Summary of Significant Accounting Policies", the Company has elected to prospectively adopt the guidance in ASU 2023-09. The following table is a reconciliation of the U.S. federal statutory rate of 21% to the Company's effective rate for the year ended December 31, 2025 in accordance with guidance in ASU 2023-09.

 

 

 

 

 

Year Ended December 31, 2025

(in thousands)

 

 

 

$

 

%

Provision for income taxes at U.S. federal statutory rate

 

 

 

$

1,861

 

 

21%

State and local income taxes, net of federal benefit (1)

 

 

 

 

956

 

 

11%

Foreign tax effects

 

 

 

 

 

 

 

 

Argentina

 

 

 

 

 

 

 

 

Withholding tax

 

 

 

 

330

 

 

4%

Colombia

 

 

 

 

 

 

 

 

Withholding tax

 

 

 

 

212

 

 

2%

El Salvador

 

 

 

 

 

 

 

 

Withholding tax

 

 

 

 

198

 

 

2%

Israel

 

 

 

 

 

 

 

 

Share-based compensation

 

 

 

 

(311)

 

 

(4)%

Foreign exchange gain/loss

 

 

 

 

(770)

 

 

(9)%

Other

 

 

 

 

(193)

 

 

(2)%

Peru

 

 

 

 

 

 

 

 

Withholding tax

 

 

 

 

209

 

 

2%

Switzerland

 

 

 

 

 

 

 

 

Valuation allowance

 

 

 

 

(464)

 

 

(5)%

Withholding tax deduction

 

 

 

 

(245)

 

 

(3)%

Other

 

 

 

 

(275)

 

 

(3)%

Other foreign jurisdictions

 

 

 

 

367

 

 

4%

Effect of changes in tax laws or rates enacted in the current period

 

 

 

 

 

 

 

 

Effect of cross-border tax laws:

 

 

 

 

 

 

 

 

Global intangible low-taxed income

 

 

 

 

2,084

 

 

24%

Branch income inclusion

 

 

 

 

588

 

 

7%

Other

 

 

 

 

(212)

 

 

(2)%

Tax credits:

 

 

 

 

 

 

 

 

Foreign tax credits

 

 

 

 

(986)

 

 

(11)%

Research and development credits

 

 

 

 

(268)

 

 

(3)%

Valuation allowance

 

 

 

 

 

 

 

 

Non-taxable or non-deductible items:

 

 

 

 

 

 

 

 

Share-based compensation

 

 

 

 

1,529

 

 

17%

Impairment loss

 

 

 

 

1,013

 

 

11%

Other

 

 

 

 

503

 

 

6%

Uncertain tax positions

 

 

 

 

1,467

 

 

17%

Adjustment to prior period provision

 

 

 

 

 

 

 

 

Other adjustments

 

 

 

 

52

 

 

1%

Total tax provision and effective tax rate

 

 

 

$

7,645

 

 

86%

 

(1) State taxes in New Jersey, Tennessee, and Utah made up the majority (greater than 50%) of the tax effect in this category.

The company's effective tax rate of 86% for the year ended December 31, 2025 was due primarily to tax expense related to the method change for capitalization of research and development expenses under Section 174 of the Internal Revenue Code, which reduced our Internal Revenue Code Section 250 tax benefits, and the geographical mix of income and losses.

The difference between the tax provision at the statutory federal income tax rate and the provision for (benefit from) income tax as a percentage of income (loss) before income taxes (effective tax rate) for the years ended December 31, 2024 and 2023 in accordance with guidance prior to the adoption of ASU 2023-09 was as follows:

 

 

 

 

Year Ended December 31,

 

 

 

2024

 

2023

Statutory U.S. federal income tax rate

 

 

 

 

21%

 

 

21%

Increase (reduction) in rate resulting from:

 

 

 

 

 

 

 

 

State Taxes

 

 

 

 

4%

 

 

%

Differential in rates on foreign earnings

 

 

 

 

2%

 

 

(6)%

Change in valuation allowance

 

 

 

 

%

 

 

(243)%

Non-deductible stock-based compensation

 

 

 

 

2%

 

 

5%

Permanent differences

 

 

 

 

(1)%

 

 

%

Adjustments related to tax positions taken during prior years

 

 

 

 

2%

 

 

8%

Research and development credits

 

 

 

 

(1)%

 

 

(2)%

Effective tax rate

 

 

 

 

29%

 

 

(217)%

 

The Company’s effective tax rate of 29% for the year ended December 31, 2024 was due primarily to tax expense related to the geographical mix of income and losses and the resulting income and withholding taxes from operations in the foreign tax jurisdictions, offset by federal tax credits.

The Company’s effective tax rate of (217)% for the year ended December 31, 2023 was due primarily to tax benefit related to the release of the valuation allowance against U.S. Federal and certain state deferred tax assets due to improved historical earnings and projected earnings.

The Company operates in multiple jurisdictions and its profits are taxed pursuant to the tax laws of these jurisdictions. The Company’s effective income tax rate differs from the U.S. federal statutory rate primarily due to geographical mix of income and losses, non-deductible stock-based compensation, and the resulting income and withholding taxes from operations in the foreign tax jurisdictions. The Company’s effective income tax rate may be affected by changes in its interpretations of tax laws and tax agreements in any given jurisdiction, changes in geographical mix of income and expense, and changes in management's assessment of matters such as the ability to realize deferred tax assets, as well as one-time discrete items.

The components of deferred taxes are as follows:

 

 

 

 

As of December 31,

(in thousands)

 

 

 

 

2025

 

 

2024

Deferred tax assets:

 

 

 

 

 

 

 

 

Reserves and accruals

 

 

 

$

21,336

 

$

22,100

Net operating loss carryforwards

 

 

 

 

19,203

 

 

3,327

Research and development credit carryforwards

 

 

 

 

30,630

 

 

30,350

Deferred stock-based compensation

 

 

 

 

1,176

 

 

2,341

Intangibles

 

 

 

 

3,695

 

 

4,385

Operating lease liabilities

 

 

 

 

3,377

 

 

3,841

Capitalized research and development expenses

 

 

 

 

56,181

 

 

83,054

Other

 

 

 

 

5,249

 

 

3,219

Gross deferred tax assets

 

 

 

 

140,847

 

 

152,617

Valuation allowance

 

 

 

 

(32,992)

 

 

(33,397)

Gross deferred tax assets after valuation allowance

 

 

 

 

107,855

 

 

119,220

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Depreciation

 

 

 

 

(1,952)

 

 

(3,127)

Operating lease right-of-use assets

 

 

 

 

(1,860)

 

 

(2,187)

Gross deferred tax liabilities

 

 

 

 

(3,812)

 

 

(5,314)

Net deferred tax assets

 

 

 

$

104,043

 

$

113,906

 

The following table summarizes the activities related to the Company’s valuation allowance:

 

 

Year Ended December 31,

(in thousands)

 

2025

 

 

2024

 

 

2023

Balance at beginning of period

$

33,397

 

$

32,869

 

$

97,315

Additions

 

 

 

528

 

 

31

Deductions

 

(405)

 

 

 

 

(64,477)

Balance at end of period

$

32,992

 

$

33,397

 

$

32,869

The Company's valuation allowance as of December 31, 2025, was lower compared to 2024, primarily due to a release of valuation allowance on the net operating loss (“NOL”) for Switzerland, partially offset by an increase related to newly generated California R&D credits.

Management regularly assesses the ability to realize deferred tax assets recorded based upon the weight of available evidence, including such factors as recent earnings history and expected future taxable income on a jurisdiction-by-jurisdiction basis. In 2023, the Company determined that deferred tax assets in the U.S federal and certain state jurisdictions would be realizable and released the valuation allowance against those assets accordingly. In the event that the Company changes its determination as to the amount of realizable deferred tax assets, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made.

As of December 31, 2025, the Company had $70 million, $6.3 million, and $24.9 million, of federal, foreign, and U.S. state NOL carryforwards, respectively. The federal NOLs will carryforward indefinitely. Certain foreign NOLs expire beginning in 2026, if not utilized, while the majority of the foreign NOLs carryforward indefinitely. Certain U.S states NOLs carryforward expires at various dates beginning in 2030 if not utilized.

As of December 31, 2025, the Company had U.S. federal and California state tax credit carryforwards of approximate $4.9 million and $37.1 million, respectively. If not utilized, the U.S. federal tax credit carryforwards will begin to expire in 2031, while the California tax credit carryforward will not expire.

In the event the Company experiences an ownership change within the meaning of Section 382 of the Internal Revenue Code (“IRC”), the Company’s ability to utilize U.S. net operating losses, tax credits and other tax attributes may be limited.

The Company has not provided U.S. state income taxes and foreign withholding taxes, on the cumulative earnings for certain non-U.S. subsidiaries, because such earnings are intended to be indefinitely reinvested. Determination of the amount of unrecognized deferred tax liability for temporary differences related to investments in these non-U.S. subsidiaries that are essentially permanent in duration is not practicable.

The Company applies the provisions of the applicable accounting guidance regarding accounting for uncertainty in income taxes, which require application of a more-likely-than-not threshold to the recognition and derecognition of uncertain tax positions. If the recognition threshold is met, the applicable accounting guidance permits the recognition of a tax benefit measured at the largest amount of such tax benefit that, in the Company’s judgment, is more than fifty percent likely to be realized upon settlement. It further requires that a change in judgment related to the expected ultimate resolution of uncertain tax positions to be recognized in earnings in the period in which such determination is made. The Company will continue to review its tax positions and provide for, or reverse, unrecognized tax benefits as issues arise. As of December 31, 2025, the Company had $13.8 million of unrecognized future tax benefits, including interest and penalties. Of these, $5.6 million would favorably impact the effective tax rate in future periods if recognized, and $8.2 million will have no or minimal impact on the effective tax rate in future periods if recognized due to a valuation allowance on such unrecognized tax benefits.

The following table summarizes the activities related to the Company’s gross unrecognized tax benefits:

 

 

Year Ended December 31,

(in millions)

 

2025

 

 

2024

 

 

2023

Balance at beginning of period

$

12.0

 

$

12.5

 

$

11.1

Increase in balance related to tax positions taken during current year

 

0.1

 

 

0.2

 

 

0.4

Increase in balance related to tax positions taken during prior years

 

1.2

 

 

0.3

 

 

1.0

Decrease in balance related to tax positions taken during prior years

 

(0.2)

 

 

(1.0)

 

 

Balance at end of period

$

13.1

 

$

12.0

 

$

12.5

The Company recognizes interest and penalties related to unrecognized tax positions in income tax expenses on the Consolidated Statements of Operations. The net interest and penalties charges recorded for the years ended December 31, 2023 through 2025, were not material.

The 2022 through 2024 tax years generally remain subject to examination by U.S. federal and most state tax authorities. Net operating losses generated on a tax return basis by the Company for the 2015 to 2020 tax years and research and development credits for 2011 to 2024 tax years remain open to examination. In addition, the Company remains subject to income tax examination for several other jurisdictions, including in Switzerland for years after 2019, Israel for years after 2019, and France for years after 2023.

During the year ended December 31, 2025, the Company paid $10.5 million in federal income taxes. The amounts paid in state and foreign income taxes, net of refunds received, were $1.6 million and $0.6 million, respectively for the same period.

Historical Timeline

Fiscal YearFiled
2025Feb 24, 2026Showing above
2024Feb 14, 2025

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.